Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04469296 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Diet Modification in pAtients With Luminal Early Breast Cancer Candidate for Primary Surgery

Study acronym: MACS
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion dates: Apr 2026 to Dec 2026v11
  2. Re-verified, no change to tracked fieldsv10
  3. Primary and study completion dates: Mar 2025 to Apr 2026v9
  4. Primary and study completion dates: Jul 2024 to Mar 2025v8
  5. Start date: Mar 26, 2021 to May 18, 2021
    • Primary and study completion dates: May 2024 to Jul 2024
    • Secondary endpoints: details revised at 1 of 8 entries
    • Eligibility criteria expanded, about 2 words
    v7
Show 5 earlier versionsHide 5 earlier versions
  1. Primary and study completion dates: May 2022 to May 2024v6
  2. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Apr 2021 to Mar 26, 2021
    • Site details revised
    v5
  3. Start date: Jan 2021 to Apr 2021v4
  4. Start date: Jul 31, 2020 to Jan 2021v3
  5. Secondary endpoints: 7 to 8v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
to analyze the feasibility for patients with early luminal breast cancer to be compliant with a diet modification - ketogenic or proteins restricted diet - during 9 +/- 1 days, before breast cancer surgery. It's a Pilot study, monocentric, randomized
Trial Details
NCT Number NCT04469296
Lead Sponsor Institut du Cancer de Montpellier - Val d'Aurelle
Conditions
(from sponsor)		 Breast Cancer, Surgery
Related terms Breast Neoplasms
Enrollment 75 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov